Publication
Title
Interferon $\alpha$ may be back on track to treat acute myeloid leukemia
Author
Abstract
 Our own experience and a thorough literature review suggest that interferon α (IFNα) should be reconsidered for the treatment of acute myeloid leukemia patients. Most likely, the success of such treatment depends on the achievement of high serum levels of IFNα for several months, which can be obtained by using pegylated IFNα.
Language
English
Source (journal)
Oncoimmunology
Publication
2013
ISSN
2162-4011
2162-402X
Volume/pages
2 :4 (2013)
Article Reference
e23619
ISI
000322566200015
Medium
E-only publicatie
Full text (Publisher's DOI)
Full text (open access)
UAntwerpen
 Faculty/Department Research group Publication type Subject Affiliation Publications with a UAntwerp address
External links
 Web of Science
Record
 Identifier Creation 13.03.2013 Last edited 15.11.2022 To cite this reference